ArticleJournal of cancer research and clinical oncology2020

Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach.

Fuhai Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.